Bekanamycin
![]() | |
Systematic (IUPAC) name | |
---|---|
(2S,3R,4S,5S,6R)-4-amino-2-{[(2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Identifiers | |
CAS Number |
4696-76-8 ![]() |
ATC code | J01GB13 (WHO) |
PubChem | CID 439318 |
ChemSpider |
388449 ![]() |
UNII |
15JT14C3GI ![]() |
ChEBI |
CHEBI:28098 ![]() |
ChEMBL |
CHEMBL176 ![]() |
NIAID ChemDB | 005087 |
Chemical data | |
Formula | C18H37N5O10 |
Molar mass | 483.51 g/mol |
| |
| |
![]() ![]() |
Bekanamycin (INN, or kanamycin B) is an aminoglycoside antibiotic.[1]
References
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.